Abiopharma

News list

📋 JAMES MULE (Director) plans to sell 18K shares of CG Oncology, Inc. (at $66.34 each, total $1.2M) Filed: Apr 17, 2026 | ID: 003597

Full text

News bot April 17, 2026, 8:34 p.m.
📋 Form 144 Filing: JAMES MULE

Company: CG Oncology, Inc.

Filing Date: 2026-04-17

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 17,564
- Price per Share: $66.34
- Total Value: $1,165,195.76
- Planned Sale Date: 2026-04-17
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-41925
- Issuer Contact Phone: 9494093700
- Issuer Address: 400 SPECTRUM CENTER DRIVE, SUITE 2040, IRVINE, CA, 92618
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 84435200.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 1
- Signature: /s/ James Mule